|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
1,430,000,000 |
Market
Cap: |
110.27(B) |
Last
Volume: |
6,919,020 |
Avg
Vol: |
8,403,954 |
52
Week Range: |
$48.64 - $76.12 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 297 |
Guru Rank Value : 4.1 |
Guru Occurances : 2 |
|
|
|
|
|
|
|
Company Profile Boston Scientific develops, manufactures and markets medical devices. Co.'s Medical Surgical segment consist of: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat various urological and pelvic conditions. Co.'s Rhythm and Neuro segment includes: Cardiac Rhythm Management, which develops and manufactures implantable devices to treat cardiac abnormalities; and Electrophysiology, which develops and manufactures medical technologies used in the diagnosis and treatment of rate and rhythm disorders of the heart.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
319,019 |
515,317 |
1,014,661 |
2,126,174 |
Total Sell Value |
$23,643,548 |
$35,409,189 |
$61,747,133 |
$111,248,213 |
Total People Sold |
9 |
10 |
11 |
13 |
Total Sell Transactions |
15 |
27 |
45 |
80 |
End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mahoney Michael F |
Chairman, President & CEO |
|
2022-08-08 |
4 |
AS |
$40.97 |
$5,154,682 |
D/D |
(125,828) |
2,133,122 |
|
12% |
|
Mahoney Michael F |
Chairman, President & CEO |
|
2022-08-08 |
4 |
OE |
$7.39 |
$1,176,024 |
D/D |
125,828 |
2,258,950 |
|
- |
|
Connors Nelda J |
Director |
|
2022-08-02 |
4 |
S |
$41.58 |
$668,939 |
D/D |
(16,088) |
4,877 |
|
-14% |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2022-08-02 |
4 |
D |
$41.46 |
$13,267 |
D/D |
(320) |
32,602 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2022-08-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,089 |
32,922 |
|
- |
|
Thepaut Eric Francis Yves |
EVP & Pres, Eur, Mid-East, Afr |
|
2022-08-01 |
4 |
S |
$40.99 |
$847,509 |
D/D |
(20,676) |
72,486 |
|
-15% |
|
Fitzgerald Joseph Michael |
EVP & Group Pres, Cardiology |
|
2022-07-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,000 |
216,871 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-07-18 |
4 |
AS |
$38.00 |
$285,000 |
D/D |
(7,500) |
124,913 |
|
18% |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2022-07-01 |
4 |
D |
$38.01 |
$45,042 |
D/D |
(1,185) |
35,605 |
|
- |
|
Brown Vance R |
SVP, GC and Corp. Secretary |
|
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,035 |
36,790 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2022-07-01 |
4 |
D |
$38.01 |
$8,134 |
D/D |
(214) |
31,833 |
|
- |
|
Monson Jonathan |
SVP, Global Controller and CAO |
|
2022-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
728 |
32,047 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-06-24 |
4 |
AS |
$38.00 |
$285,000 |
D/D |
(7,500) |
132,413 |
|
9% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-05-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
26 |
110,290 |
|
- |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-05-16 |
4 |
AS |
$39.43 |
$295,725 |
D/D |
(7,500) |
139,913 |
|
-4% |
|
Dockendorff Charles J |
Director |
|
2022-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
4,877 |
17,079 |
|
- |
|
Scanlon Meghan |
SVP,Pres,Urology Pelvic Health |
|
2022-05-01 |
4 |
D |
$42.11 |
$25,519 |
D/D |
(606) |
24,461 |
|
- |
|
Scanlon Meghan |
SVP,Pres,Urology Pelvic Health |
|
2022-05-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,062 |
25,067 |
|
- |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-04-20 |
4 |
AS |
$46.50 |
$448,493 |
D/D |
(9,645) |
110,316 |
|
-15% |
|
Mirviss Jeffrey B. |
EVP&Pres, Periph Intervent |
|
2022-04-19 |
4 |
AS |
$45.50 |
$500,000 |
D/D |
(10,989) |
119,961 |
|
-12% |
|
Carruthers Wendy |
EVP, Human Resources |
|
2022-04-14 |
4 |
AS |
$44.47 |
$333,518 |
D/D |
(7,500) |
147,413 |
|
-6% |
|
Eddy Jodi Euerle |
SVP, Chief Info & Digital Off. |
|
2022-04-01 |
4 |
AS |
$45.00 |
$125,055 |
D/D |
(2,779) |
23,263 |
|
-7% |
|
Olson Scott |
SVP & Pres, CRM, Diagnostics |
|
2022-04-01 |
4 |
AS |
$44.55 |
$31,185 |
D/D |
(700) |
14,518 |
|
-7% |
|
Butcher Arthur C |
EVP&Pres, Asia Pacific |
|
2022-03-29 |
4 |
AS |
$45.00 |
$462,105 |
D/D |
(10,269) |
30,278 |
|
-9% |
|
Butcher Arthur C |
EVP&Pres, Asia Pacific |
|
2022-03-29 |
4 |
OE |
$16.31 |
$88,253 |
D/D |
5,411 |
40,547 |
|
- |
|
4540 Records found
|
|
Page 17 of 182 |
|
|